7:27 PM
 | 
May 24, 2018
 |  BC Extra  |  Financial News

Anti-infectives play Iterum raises $80M in IPO

Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million shares at $13 in an IPO underwritten by Leerink, RBC Capital Markets, Guggenheim and Needham. The price values Iterum at $181.5 million. Iterum slid $0.15 to $12.85 on Friday, its first day of trading.

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >